# Interoperability of data to accelerate the US Animal Drug Compounding Market
Author:  Pal Sinha, Barnali 
Author URL: https://financedigest.com/author/pal-sinha-barnali
Published: 2021-11-22
Category: Research Reports
Category URL: https://financedigest.com/category/research-reports
Meta Title: US Animal Drug Compounding Market Trends &amp; Forecast
Meta Description: Discover how the US animal drug compounding market is set to reach new heights with cloud options, digital initiatives, and alternative dosage forms. Get
URL: https://financedigest.com/interoperability-of-data-to-accelerate-the-us-animal-drug-compounding-markethtml

![undefined](https://prod.superblogcdn.com/site_cuid_cm5qst7v3003gwirgwqtxn8i8/images/research-report-1736837109348-compressed.jpg)

The US Animal Drug Compounding Market is likely to scintillate going forward. With various cloud options to explore, the healthcare industry is expected to be at a newer high in the forecast period. In other words, organizations [across the globe are advancing their downtime regarding digital business](https://www.financedigest.com/fintechs-support-of-ukraines-digital-businesses-can-be-used-as-blueprint-across-the-world.html "Fintech’s support of Ukraine’s digital businesses can be used as blueprint across the world") initiatives. They are swiftly moving towards the cloud for modernizing the environments, enhancing system reliability, supporting [hybrid work](https://www.financedigest.com/how-has-hybrid-working-impacted-the-gender-gap.html "How has hybrid working impacted the gender gap?") models, and addressing the other new-fangled realities surfacing in recent times. This would be the outlook of the healthcare vertical in the upcoming period.

Persistence Market Research published a report on the animal drug [compounding](https://www.financedigest.com/the-compounding-pharmacies-market-to-stick-around-based-on-organic-expansion.html "The Compounding Pharmacies Market to stick around based on organic expansion") market, which considers the U.S. industry analysis 2014 – 2018 and opportunity assessment 2019 – 2029, and projects that the [**animal drug compounding market**](https://www.persistencemarketresearch.com/market-research/us-animal-drug-compounding-market.asp) is expected to reach ~ **US$ 1 Bn** by the end of 2019 in terms of value, and is forecasted to reach ~ **US$ 2 Bn** by the end of 2029.

**Want Insights To US Animal Drug Compounding Market? Ask For Sample!** [**https://www.persistencemarketresearch.com/samples/30058**](https://www.persistencemarketresearch.com/samples/30058)

**Company Profiles:**

- Hoye’s Pharmacy
- Vertisis Custom Pharmacy
- Smith Caldwell Drug Store
- Sixth Avenue Medical Pharmacy
- Dougherty’s Pharmacy
- Triangle Compounding Pharmacy Inc.
- Medisca Inc.
- Wedgewood Pharmacy
- Millers Pharmacy

**Planning To Conclude Your Strategy On A Decisive Note In The US Animal Drug Compounding Market? Glance Through The “Methodology” Implied!** [**https://www.persistencemarketresearch.com/methodology/30058**](https://www.persistencemarketresearch.com/methodology/30058)

**Availability of Alternative Dosage Forms [Boosting the Demand for Animal Drug](https://www.financedigest.com/astrazeneca-lifts-2022-earnings-outlook-as-cancer-drugs-boost-results.html "AstraZeneca lifts 2022 earnings outlook as cancer drugs boost results") Compounding**

Commercially available veterinary drugs often come in a single dosage or strength. Animal drug compounding is able to produce desired drugs with alternate dosage and varied dosage forms, which is not possible during the production of branded drugs. Such types of animal drug compounding involve concentrating the drug in the flavoured gel that is generally applied to the paw or fur of the animal, and is administered by licking. Also, dosage forms such as [transdermal drug delivery](https://www.financedigest.com/medherant-announces-positive-phase-i-results-for-its-first-transdermal-drug-delivery-patch.html "Medherant announces positive Phase I results for its first transdermal drug delivery patch") in animals, are widely accepted in diverse range of animal drug compounding. To cite an example, anti-parasitic drugs for cattle and anti-flea drugs for dogs and cats are most successful transdermal drug delivery transdermal compounded drug products.

**Lower Availability of** [Generic Substitutes for Veterinary Drugs](https://www.financedigest.com/generic-oncology-drugs-market-2021-global-leading-companies-analysis-revenue-trends-and-forecasts-2027.html "Generic Oncology Drugs Market 2021 Global Leading Companies Analysis, Revenue, Trends and Forecasts 2027")

Availability of generic substitutes is much lower for veterinary drugs. Most drugs available for animals for critical diseases are branded drugs. Additionally, currently there is no reimbursement available for veterinary drugs, which indicates that most of the drug expense goes out of the pockets of animal owners. In such circumstances, most pet owners prefer resorting to animal drug compounding that are [easily available](https://www.financedigest.com/myfirmsapp-makes-real-time-autumn-budget-updates-available-digitally-on-easily-downloadable-app.html "MyFirmsApp makes real-time Autumn Budget updates available digitally on Easily Downloadable App"), cheaper than branded equivalents, and do not require multiple prescriptions.

**CNS Drugs to be Most Frequently [Dispensed Extemporaneous Medications](https://www.financedigest.com/the-medication-dispenser-market-revolve-around-digitally-driven-innovation.html "The Medication Dispenser Market revolve around digitally driven innovation") from Animal Drug Compounding Pharmacies**

Central nervous system inflammation is the most [common cause](https://www.financedigest.com/five-common-it-headaches-caused-by-long-term-working-from-home.html "Five common IT headaches caused by long-term working from home ") of neurological disorders in dogs and cats. Abnormal limb coordination, seizures, behavioral changes, and blindness are cited as the most common abnormalities in dogs and cats with central nervous system inflammation. For instance, according to the International Journal of Pharmaceutical Compounding, central nervous [system drugs were the most commonly dispensed medications](https://www.financedigest.com/the-medical-oxygen-systems-market-to-cling-to-the-digitization.html "The Medical Oxygen Systems Market to cling to the digitization") from animal drug compounding pharmacies with approximately **39%** of the total veterinary prescriptions.

**Absence of Adverse Event** [Reporting in Animal Drug Compounding](https://www.financedigest.com/animal-drug-compounding-market-report.html "Animal Drug Compounding Market Report")

Individual boards of animal drug compounding pharmacies of various states in the U.S. haven’t [reported any incidences of adverse events related to animal](https://www.financedigest.com/global-animal-healthcare-market-report.html "Global Animal Healthcare Market Report") drug compounding. Furthermore, the U.S. FDA’s adverse drug event reporting system for animals is also not aggregated or comprehensive, and is currently being revised. Since 2001, only 62 compound-related adverse events in animal drug compounding have been reported to the FDA. No definitive trends can be derived out of them. Therefore, absence of adverse event [reporting in animal drug compounding will upsurge the demand](https://www.financedigest.com/sea-bream-market-2021-current-and-future-demand-analysis-growth-and-forecast-by-2029-report.html "Sea Bream Market 2021 | Current and Future Demand, Analysis, Growth and Forecast By 2029, Report") for animal drug compounding pharmacies.

**How About Knowing The Product/Technology Driving The US Animal Drug Compounding Market Before Investing Therein? Click The “Purchase Now” Button Of Our US Animal Drug Compounding Market Report!** [**https://www.persistencemarketresearch.com/checkout/30058**](https://www.persistencemarketresearch.com/checkout/30058)

**Unsafe Compounding Practices May Deter the [Growth of Animal](https://www.financedigest.com/animal-antimicrobials-and-antibiotics-market-to-rear-excessive-growth-during-2020-2030.html "Animal Antimicrobials and Antibiotics Market to Rear Excessive Growth During 2020-2030 ") Drug Compounding**

The primary factor restraining the usage of animal drug compounding is unsafe compounding practices, which include compounding contaminations and non-adherence to GMP regulations. This is very prominent across [sterile compounding involving injectable drugs](https://www.financedigest.com/precise-remote-monitoring-to-steal-the-sterile-injectable-drugs-market.html "Precise Remote Monitoring to steal the Sterile Injectable Drugs Market") and intravenous solutions. Contaminated sterile environments lead to spread of pathogens and fungal infections, and have resulted in various hazards and drug-related deaths, thus dampening the prospects for animal drug compounding. To avoid unsafe animal drug compounding practices, the U.S. FDA has made it mandatory for all outsourcing facilities [manufacturing bulk drugs](https://www.financedigest.com/how-are-fumed-silica-applications-rising-in-paints-coatings-and-drug-manufacturing.html "How are Fumed Silica Applications Rising in Paints & Coatings and Drug Manufacturing") to be inspected and to secure cGMP certification.

**About Us:** [**Persistence Market Research**](https://www.persistencemarketresearch.com/about-us.asp)

**Contact Us:**

**[Persistence Market](https://www.financedigest.com/the-kidney-dialysis-equipment-market-to-stay-innovatively-persistent.html "The Kidney Dialysis Equipment Market to stay innovatively persistent") Research**

Address – 305 Broadway, 7th Floor, New York City,

NY 10007 United States

U.S. Ph. – +1-646-568-7751

USA-Canada Toll-free – +1 800-961-0353

**Japan Office:** 1-2-1 Kinshi Arca Central Building

14/F Tokyo, 130-0013, Japan

Call 1-888-863-3700

**Sales** – sales@persistencemarketresearch.com

**Website** – [https://www.persistencemarketresearch.com](https://www.persistencemarketresearch.com/)


---
This blog is powered by Superblog. Visit https://superblog.ai to know more.
---

